Biomarker Identification of Radionuclide Therapy-induced Radiation Responses
NCT05513469
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
Lutathera
Sponsor
Erasmus Medical Center